Tricaprilin

Unassigned

New Medicines

Alzheimer's disease, mild-to-moderate

Information

New molecular entity
Cerecin
Cerecin

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Glucose stimulant
Alzheimer disease is the most common form of dementia, accounting for around 50% of cases, and is estimated to affect up to 500,000 people in the UK. Between 50% and 64% are estimated to have mild to moderately severe disease [2,3].
Alzheimer's disease, mild-to-moderate
Oral